跳至主要内容
临床试验/EUCTR2016-001611-20-DE
EUCTR2016-001611-20-DE进行中(未招募)1 期

Pathophysiology-based therapy of epileptic encephalopathies

niversity of Tübingen0 个研究点目标入组 25 人开始时间: 2016年9月26日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - highly active epilepsy (one or more seizures per day) with onset at 3 months of age or before - pharmo-resistance (2 or more anticonvulsive medications tried before with no effect) - max. 2 stable anticonvulsive drugs at study start
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 25
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • - high-grade cardial rhythm disease - severe pathology of liver or renal function - severe change in blood counts or electrolytes - metabolic or lesional epilepsy

研究者

发起方
niversity of Tübingen

相似试验

Cause-based treatment of patients with therapy... | 临床试验